Understanding and treating neurological disorders
Welcome to the Department of Neurology and Neurological Sciences at Stanford!
The Department has been a center of excellence for more than four decades and includes over 140 School of Medicine faculty members with primary academic appointments in the Department at our four outstanding teaching hospitals and health care systems. The Stanford Health Care (SHC) new 824,000 square-foot state-of-the-art hospital opened in 2019 with over 600 beds, making it one of the largest inpatient facilities in California. Ranked in the top 10 for Neurology and Neurosurgical Care by US News and World Report, SHC is at the cutting edge of the latest treatments for neurological diseases. SHC boasts a dedicated outpatient Stanford Neuroscience Health Center—a facility like no other on the West Coast—as well as clinics located throughout Northern California. With over 60,000 annual outpatient visits and thus one of the largest neurology volumes in the U.S., Stanford Neurology provides care for a large and highly diverse patient population and supports excellence in clinical care, education, and research.
Frank M. Longo, MD, PhD
George and Lucy Becker Professor and Chair Department of Neurology and Neurological Sciences
Neurology News
National Academy of Medicine Elects 100 New Members
Michelle Monje, MD, PhD was elected as a NAM member - considered one of the highest honors in the fields of health & medicine recognizing individuals who demonstrate outstanding professional achievement & commitment to service. Read more
New ways to prevent — or even reverse — dementia, paralysis and blindness
In the past few decades, researchers have devised methods to manipulate the brain and central nervous system to help the paralyzed move, enable the blind to see, and move closer to restoring lost cognitive abilities. Read more
Opening stroke’s window
On a mission to defend more stroke patients from a life of disability, Stanford Medicine colleagues drive research that extends the window for effective intervention. Read more
Can major surgery increase risk for Alzheimer’s disease?
Dr. Greicius and colleagues in anesthesia (Igor Feinstein and Martin Angst), have shown that p-tau181, a blood-based Alzheimer’s biomarker, increases significantly during surgery and rises to levels typically seen in patients with Alzheimer’s disease. The p-tau181 levels slowly decline after surgery but remain elevated in some patients for at least two days after surgery. The study paves the way for future work that will try to link molecular changes induced by surgery to the longer term post-operative decline that occurs in some surgical patients. Read more
Neuroscientist Michelle Monje awarded MacArthur 'genius grant'
The neuroscientist and pediatric neuro-oncologist is being recognized for her work to understand healthy brain development and create therapies for a group of lethal brain tumors. Read more
How Tri-Valley hospital helps patients survive stroke
Stanford Health Care – ValleyCare's stroke program is recognized for its commitment to meeting rigorous national standards of stroke care. Read more
Ground Rounds
Neurology Grand Rounds will continue as ZOOM only for the foreseeable future. See email for link & password
Oct October 22 Fri 2021
Clinical Pathology Case
Katherine Clifford, MD
Neurology PGY-3 Resident
Stanford University School of Medicine
Stanford Neuroscience
Stanford Health Care provides comprehensive care and treatment for neurological disorders.
Wu Tsai Neurosciences Institute
The Department of Neurology and Neurological Sciences is a member of the Wu Tsai Neurosciences Institute.
Social Media
